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VLA-4 is a heterodimeric integrin composed   
of 4 and 1 subunits (Pribila et al., 2004). 
The monoclonal antibody natalizumab directed 
against 4 was introduced into the treatment of 
multiple sclerosis (MS) because it had been 
recognized that encephalitogenic T cells used 
VLA-4 to infiltrate the central nervous system 
(CNS; Yednock et al., 1992; Baron et al., 1993; 
von Andrian and Engelhardt, 2003; Polman   
et al., 2006). Early studies in adoptive transfer 
experimental autoimmune encephalomyelitis 
(EAE) in mice suggested that only VLA-4–
expressing  CNS  antigen-specific  T  cell  lines 
were  able  to  induce  EAE,  and  blockade  of 
VLA-4 by antibodies to 4 abrogated their en-
cephalitogenic potential (Baron et al., 1993; 
Kuchroo et al., 1993). Short-term T cell lines 
and encephalitogenic T cell clones are heavily 
biased toward production of IFN- and fail to 
secrete IL-4 and IL-13 (Kuchroo et al., 1995). 
Hence, Th1 cytokine signature and VLA-4 ex-
pression co-segregate in encephalitogenic T cells. 
However, it is now clear that Th17 cells whose 
transcriptional program is essentially distinct 
from Th1 cells are also able to induce EAE 
(Jäger  et  al.,  2009;  Domingues  et  al.,  2010). 
Th17 cells even appear superior to Th1 cells in 
their strength to induce tissue inflammation in 
solid organs and thus have recently been associ-
ated with a variety of autoimmune diseases in-
cluding psoriasis, rheumatoid arthritis, and MS 
(Murphy et al., 2003; Langrish et al., 2005; 
Hirota et al., 2007; Zheng et al., 2007; Lowes 
et al., 2008; Durelli et al., 2009; Kebir et al., 
2009). Th17 cells express the IL-23 receptor 
(IL-23R),  and  the  exquisite  pathogenicity  of 
Th17 cells may be associated with their capacity 
to  respond  to  IL-23  (Mangan  et  al.,  2006; 
Manel  et  al.,  2008;  Awasthi  et  al.,  2009;   
McGeachy et al., 2009).
Although it has been suggested in a recent 
study that the chemokine receptor CCR6 guides 
the entry of Th17 cells into the CNS through 
the ependymal layer (Reboldi et al., 2009), it has 
not yet been directly addressed whether Th1 
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The integrin 41 (VLA-4) is used by encephalitogenic T cells to enter the central nervous 
system (CNS). However, both Th1 and Th17 cells are capable of inducing experimental 
autoimmune encephalomyelitis (EAE), and the molecular cues mediating the infiltration of 
Th1 versus Th17 cells into the CNS have not yet been defined. We investigated how block-
ing of 4 integrins affected trafficking of Th1 and Th17 cells into the CNS during EAE. 
Although antibody-mediated inhibition of 4 integrins prevented EAE when MOG35-55-specific 
Th1 cells were adoptively transferred, Th17 cells entered the brain, but not the spinal cord 
parenchyma, irrespective of 4 blockade. Accordingly, T cell–conditional 4-deficient  
mice were not resistant to actively induced EAE but showed an ataxic syndrome with pre-
dominantly supraspinal infiltrates of IL-23R+CCR6+CD4+ T cells. The entry of 4-deficient 
Th17 cells into the CNS was abolished by blockade of LFA-1 (L2 integrin). Thus, Th1 cells 
preferentially infiltrate the spinal cord via an 4 integrin–mediated mechanism, whereas the 
entry of Th17 cells into the brain parenchyma occurs in the absence of 4 integrins but is 
dependent on the expression of L2. These observations have implications for the under-
standing of lesion localization, immunosurveillance, and drug design in multiple sclerosis.
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abolished the disease in T cell conditional 4 integrin–deficient 
mice but resulted in severe EAE in wild-type animals. We 
conclude that expression of 4 integrin is necessary and suffi-
cient for myelin antigen-specific Th1 cells to enter the CNS. 
However, Th17 cells are able to use 2 integrins to infiltrate 
into the CNS and are able to enter the target tissue indepen-
dently of 4 integrin expression.
RESULTS
Th17 cells express lower amounts of 4 integrin than Th1 cells
Both Th1 and Th17 cells are capable of inducing EAE. We 
were interested in evaluating whether Th1 and Th17 cells used 
different integrins to enter the CNS compartment. Because 
heterodimeric 41 (VLA-4) has been identified to be essential 
for encephalitogenic T cells to invade the CNS (Baron et al., 
1993), we first tested the expression profile of 4 integrin in 
Th1 and Th17 cells. Naive T cells (CD4+CD44Foxp3) were 
purified from the peripheral immune compartment of Foxp3gfp 
knockin (Foxp3gfp.KI) mice and differentiated into Th1 or Th17 
cells in vitro (Fig. 1 A). On day 4 after start of differentiation, 
and Th17 cells use different entry routes into the CNS. Even 
though it has been suggested that Th17 cells might rely on 
other integrins as compared with Th1 cells when crossing the 
blood/cerebrospinal fluid barrier or the blood–brain barrier 
(Wang et al., 2007; Kebir et al., 2009), the use of particular   
integrins by Th1 cells versus Th17 cells has not yet been corre-
lated with the accumulation of encephalitogenic T cell subsets 
in topographically distinct niches of the CNS. In the present 
study, we investigated the requirement for 4 integrins, par-
ticularly VLA-4 (41, CD49d/CD29), and also the 2 inte-
grin LFA-1 (L2, CD11a/CD18) in the entry of T cell subsets 
into the CNS. We observed that 4 integrin is down-regulated   
in the Th17 expression profile, whereas antigen-specific Th1 
cells expressed high amounts of 4 integrin. Accordingly, Th1 
cell–mediated EAE, but not Th17 cell–mediated EAE, was 
blocked by a monoclonal antibody to 4 integrin. Under   
4 blockade, recipients of encephalitogenic Th17 cells devel-
oped atypical EAE with ataxic hemiparesis, a clinical pheno-
type which was recapitulated in actively induced EAE of T cell 
conditional 4-deficient mice. Blockade of LFA-1 completely 
Figure 1.  Expression of 4 integrin mRNA and protein 
are down-regulated in Th17 cells. (A) Purified naive T cells 
(CD4+CD44Foxp3) isolated from Foxp3gfp.KI mice were 
cultured under Th0 (no cytokines), Th1 (IL-12 and anti–IL-4), 
or Th17 (TGF- plus IL-6 ± IL-23) polarizing conditions with 
polyclonal TCR stimulation. On day 3, expression of 4 inte-
grin was determined by surface staining (top row: tinted line, 
isotype control; black line, -4 integrin). The differentiation 
status was confirmed by intracellular cytokine staining (bot-
tom row: numbers indicate percentages of cytokine-positive 
cells). Shown are representatives of more than five indepen-
dent experiments. (B) Time course of 4 integrin expression 
during Th1 and Th17 differentiation as determined by sur-
face staining (means + SD, n = 4, Student’s t test). (C) RNA 
was isolated from T cells that had been stimulated under Th1 
or Th17 polarizing conditions at indicated time points. Rela-
tive expression of 4 integrin was determined by quantita-
tive RT-PCR analysis. Bars indicate fold change in relative 
expression of 4 integrin in Th1 versus Th17 cells. Shown are 
representatives of four independent experiments. (D) Naive  
T cells (CD4+CD44Foxp3) from 2D2 × Foxp3gfp.KI MOG35-55- 
specific TCR transgenic mice were cultivated 1:5 with  
irradiated syngeneic splenocytes as APCs and 20 µg/ml 
MOG35-55 peptide under Th1 or Th17 polarizing conditions, 
respectively. 4 integrin expression and cytokine status were 
determined on day 4 after the start of differentiation by flow 
cytometry. Shown are representatives of two independent 
experiments. (E) Naive (CD4+CD44CD25) T cells were FACS 
sorted and polarized under Th1 or Th17 conditions (R1). After 
a resting phase, T cells were restimulated by plate-bound 
anti-CD3 and soluble anti-CD28 antibodies in the presence 
of IL-12 or IL-23 (R2) and allowed to proliferate for another 
3 d before analyzing the expression levels of surface 4 
integrin and intracellular IL-17 and IFN- by flow cytometry 
(numbers indicate percentages of cytokine-positive cells).  
In the histogram plots, numbers indicate mean fluorescence 
intensity (MFI) of 4 integrin surface expression in Th1 (black 
numbers) or Th17 cells (gray numbers), respectively. Shown 
are representatives of two independent experiments.JEM Vol. 208, No. 12 
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differentiation conditions was equally observed when purified 
naive MOG35-55-specific TCR transgenic T cells (2D2) were 
stimulated with their cognate antigen in the presence of   
antigen-presenting cells (Fig. 1 D). When Th17 cells were 
removed from the differentiation culture and rested, 4 inte-
grin was reexpressed to some extent although Th1 levels were 
never reached. Upon round two of restimulation in the presence 
of IL-23, committed Th17 cells kept down-regulating the ex-
pression of 4 again. In contrast, Th1 cells showed elevated 
amounts of 4 integrin throughout the primary and secondary 
cultures (Fig. 1 E). Thus, decreased levels of 4 expression   
appear to be associated with the Th17 but not the Th1 develop-
mental pathway.
Entry of Th1 but not Th17 cells into CNS is blocked  
by antibodies to 4 integrin in adoptive transfer EAE
To determine the functional relevance of the down-regulation 
of 4 in Th17 cells in an EAE model, naive CD4+CD44CD25 
T cells from 2D2 mice were FACS sorted and differentiated into 
Th1 or Th17 cells in vitro, followed by transfer into Rag1-
deficient recipient mice. 2 × 106 IFN- or IL-17 single produc-
ers were transferred, respectively. Before transfer, Th1 and Th17 
cells were incubated with control immunoglobulin or blocking 
antibodies to 4 integrin (PS/2) and after transfer, host mice 
cytokine expression profile and expression of 4 integrin 
(CD49d) were determined by flow cytometry and quantitative 
RT-PCR (Fig. 1, A–C). Under Th1 differentiation conditions, 
T cells expressed IFN- and high amounts of 4 integrin 
throughout the differentiation culture. In contrast, differentia-
tion of naive T cells into the Th17 phenotype was associated 
with a significant decrease in 4 integrin expression both on the 
protein and mRNA levels irrespective of whether or not IL-23 
was present during T cell differentiation (Fig. 1, A and B). The 
decrease of 4 integrin expression under Th17, but not Th1, 
Figure 2.  In adoptive transfer EAE, antigen-specific Th17, but not 
Th1, cells enter into CNS independently of 4 blockade. (A) Naive 
CD4+CD44CD25 T cells from 2D2 MOG35-55-specific TCR transgenic mice 
were polarized under Th1 or Th17 conditions in vitro. On day 3, cytokine 
status was checked by intracellular cytokine staining and 2 × 106 cytokine-
positive cells were injected i.v. into Rag1/ mice. Before injection, polarized 
cells were incubated with control Ig or blocking antibodies to 4 integrin 
(PS/2). According to the pretreatment of the transferred cells, host mice 
were administered rIgG or anti-4 antibody every 3 d until the develop-
ment of disease. Means of clinical scores +SEM, n = 4. Note that host mice 
that received Th17 cells under conditions of 4 blockade developed signs of 
atypical EAE with ataxia and hemiparesis. (B) At the peak of disease, mono-
nuclear cells were isolated from the CNS of individual mice, stained for CD3 
and CD4, and analyzed by flow cytometry. Numbers in the histograms rep-
resent percentages of CD4+ T cells among CNS-infiltrating mononuclear cells. 
Shown are representatives of six independent experiments. (C) MOG35-55- 
specific TCR transgenic 2D2 mice were crossed to Ifng/ mice. Naive  
T cells were differentiated under Th17 conditions and transferred into 
Rag1/ mice, which were then treated with rIgG or blocking antibodies to 
4 integrin. CNS-infiltrating mononuclear cells were isolated at the peak of 
disease and stained for surface and intracellular antigens as indicated. 
Shown are representatives of three independent experiments.
Figure 3.  Encephalitogenic Th17 cells enter supraspinal parts of the 
CNS but fail to migrate into the spinal cord when 4 integrins are 
blocked. (A) Naive T cells from 2D2 mice were differentiated into Th17 cells 
in vitro and transferred into Rag1/ mice, which were treated with control 
rIgG or blocking antibodies to 4 integrin (see Fig. 2). At the peak of disease, 
the CNS was prepared and dissected into brain (brain stem, cerebellum, and 
cerebrum) and spinal cord. Mononuclear cells were isolated separately and 
analyzed by flow cytometry. Numbers indicate percentages of CD3+CD4+  
T cells within the live mononuclear cell compartment. Shown are representa-
tives of five independent experiments. (B) Quantification of absolute num-
bers of CD3+CD4+ T cells infiltrating brain or spinal cord under treatment 
with control rIgG or antibodies to 4 (mean + SD, n = 4).2468 Differential CNS homing of Th1 and Th17 cells | Rothhammer et al.
4-dependent entry 
mechanism into the 
spinal cord but not 
into the cerebrum 
(Fig. 3, A and B).
Conditional knockout of 4 integrin in CD4+ T cells causes 
atypical EAE as a result of predominant cerebral infiltration
As experimental approaches using blocking antibodies may 
lead to an incomplete inhibition of 4 integrins, we crossed 
4flox/flox mice with CD4 Cre mice to generate conditional   
4 integrin–deficient animals, in which all T cells would lack 
4 integrin (4/ mice). As expected, CD4+ T cells did not 
express 4 integrin but displayed full differentiation ca-
pacity into Th1 and Th17 cells upon polyclonal stimulation 
in vitro (Fig. 4 A). It has been reported that engagement   
of VLA-4 within the immunological synapse might impair the 
development of Th2 cells (Mittelbrunn et al., 2004). Thus, we 
were treated with either control IgG or antibodies to 4 inte-
grin until the development of first signs of disease. In the   
absence of 4 blockade, both Th1 and Th17 cells induced 
classical EAE with ascending paralysis (Fig. 2 A). In contrast, 
treatment with anti-4 antibodies completely abrogated the 
development of signs of disease when Th1 cells were transferred 
(Fig. 2 A, left). However, blockade of 4 integrins failed to 
abolish EAE upon transfer of Th17 cells (Fig. 2 A, right). Con-
sistent with the clinical outcome, infiltration of the CNS with 
CD4+ T cells was eliminated by anti-4 treatment in Th1 cell– 
transferred animals but not in mice that received Th17 cells 
(Fig. 2 B). The cytokine phenotype of Th17 cells was unstable 
and a significant fraction of previously pure IL-17 producers   
expressed IFN- after transfer into host mice (Kurschus et al., 
2010; not depicted). Hence, we wanted to test whether re-
expression of IFN- was associated with the resistance to 4 
blockade in Th17 cells. We crossed 2D2 mice into the IFN- 
KO background and differentiated naive T cells from these mice 
into Th17 cells followed by transfer into Rag1-deficient mice 
without or with blockade of 4 integrin. Here, Th17 cells re-
mained stable IL-17 producers after transfer. However, similar to 
what we observed with regular 2D2 T cells, 4 blockade was 
not able to abrogate the entry of IFN-–deficient Th17 cells into 
the CNS (Fig. 2 C), suggesting that the initial commitment of   
T cells to the Th17 developmental program was sufficient to 
render their encephalitogenic potential resistant to 4 blockade.
Mice transferred with Th17 cells developed atypical EAE 
under  anti-4  treatment. The  animals  showed  severe  gait 
ataxia or hemiparesis, signs of cerebral rather than spinal cord 
disease (Video 1). Therefore, we dissected the spinal cord from 
the cerebrum and purified infiltrating mononuclear cells sep-
arately. Under 4 blockade, Th17 cells were prevented from 
entering the spinal cord but not the cerebrum, suggesting an 
Figure 4.  T cell differentiation and antigen- 
specific proliferation is not impaired in  
CD4 Cre × 4flox/flox mice. We generated T cell 
conditional 4 integrin knockout mice (4/) 
by crossing CD4 Cre mice with 4flox/flox mice. 
(A) Naive T cells (CD4+CD44CD25) from 
4/ mice were isolated by FACS sorting and 
differentiated in vitro by stimulation with anti-
CD3/anti-CD28 under Th1 or Th17 polarizing 
conditions. Surface staining for 4 integrin (top 
row: tinted line, isotype control; black line,  
anti–4 integrin) and intracellular cytokine 
staining for IL-17 and IFN- (bottom row) are 
depicted. Numbers indicate percentages of 
cytokine-positive cells. Shown are representa-
tives of three independent experiments.  
(B and C) 4/ mice and wild-type littermates 
were immunized with MOG35-55 in CFA. On day 8,  
draining lymph nodes were dissected and re-
stimulated with MOG35-55 in vitro. After 48 h, the 
antigen-specific proliferative response was  
determined by 3H-thymidine incorporation  
(B, means + SD, n = 3). (C) Fractions of antigen-
specific cytokine-producing CD4+ T cells in 
draining lymph nodes of MOG35-55-immunized 
wild-type and conditional 4/ mice were 
determined by intracellular CD40L (CD154) and 
cytokine staining after restimulation with 
MOG35-55. Numbers indicate percentages  
of cytokine/CD40L double-positive cells  
(C, means ± SEM, n = 3).
Figure 5.  4/ mice develop atypical EAE. EAE was induced in 4/ 
mice or wild-type control animals by immunization with MOG35-55 in CFA and 
disease severity was monitored according to the classical EAE score (mean 
clinical score + SEM, n = 5). Note that 4/ mice developed an ataxic EAE 
syndrome whose severity is only partially reflected in the classical EAE score.JEM Vol. 208, No. 12 
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tested the in vivo sensitization against MOG35-55 in 4/ mice 
in a quantitative and qualitative manner. After active im-
munization with MOG35-55, CD4+ T cells from draining lymph 
nodes of T cell conditional 4-deficient animals showed 
high MOG35-55-specific recall responses that were similar to 
recall responses in wild-type mice (Fig. 4 B). Also, the amounts   
of  IFN-  and  IL-17  that  were  produced  by  MOG35-55- 
activated CD4+CD40L+ T cells from draining lymph nodes 
were equivalent in wild-type and 4/ mice (Fig. 4 C). 
These data suggested that antigen-specific sensitization with 
MOG35-55 in CFA was not impaired under conditions of   
T cell–restricted absence of 4 integrin.
As compared with their wild-type littermates, which de-
veloped classical EAE, 4/ mice immunized with MOG35-55 
in CFA mainly developed atypical disease with hemiparesis or 
ataxic gait (Fig. 5). When analyzing the sites of immunopath-
ological damage within the CNS, we found that cellular in-
filtrates in 4/ mice were localized in the brain stem, 
cerebellum, and cerebrum, whereas the load of immune cell 
infiltration in the spinal cord was markedly reduced as com-
pared with wild-type littermates (Fig. 6 A). T cell recruitment 
around meningeal vessels and perivascular T cell accumula-
tion within the CNS parenchyma was prominent in wild-type 
mice, suggesting a vascular recruitment pattern in the CNS 
and especially in the spinal cord of wild-type mice (Fig. 6 A). 
In contrast, 4/ mice showed marked immune cell infil-
trates within the plexus epithelium or in the brain parenchyma 
adjacent to the cerebral ventricles (Fig. 6 A). Parenchymal 
T cell infiltrates in the spinal cord were markedly reduced in 
4/ mice as compared with their wild-type counterparts 
(Fig. 6 A). Colocalization of IL-17 with T cells was most 
clearly  observed  in  the  ventricle-associated  areas  of  4/ 
mice (Fig. 6 B). Together, these data indicated that encephali-
togenic T cells might be redirected to cerebrospinal fluid–
associated anatomical niches in the absence of 4 integrin 
expression. We then determined the number and functional 
phenotype of CD4+ T cells recovered from the brain and 
spinal cord in a quantitative manner by flow cytometry. Here, 
we observed that the absolute numbers of CD4+ T cells at the 
peak of disease were significantly lower in the spinal cord   
(but not the brain) of 4/ mice as compared with wild-type 
littermates (Fig. 7, A and B). The cytokine profile of T cells 
(IL-17, IFN-, and IL-17/IFN- double-positive CD4+  
T cells) infiltrating the cerebrum was comparable between 
wild-type and 4/ mice. However, in the spinal cord of 
4/ mice, there was a significant reduction in the number of   
Figure 6.  4/ mice develop atypical EAE as a result of predomi-
nant cerebral immune cell infiltration. At the peak of disease (i.e., on day 18   
after immunization), coronal brain sections and transverse lumbar spinal 
cord sections were prepared from MOG35-55-immunized wild-type and 4/ 
mice. (A) Light microscopy of sections stained with hematoxylin and eosin 
(a–f and k–p) and immunofluorescence imaging of sections stained for CD3 
(green, g–j and q–t). Note that there were hardly any CD3+ T cells in the 
plexus epithelium of wild-type mice (c and g), whereas inflammatory infil-
trates were identified beneath the glia limitans (d and h). In contrast, 4/ 
animals showed T cells associated with the plexus epithelium (m and q) as 
well as the meninges (n and r). The arrowheads in m indicate inflammatory 
cells associated with ventricular epithelium lining. The arrow in m designates 
a ventricular epithelium lining cell. (B) Double immunofluorescence staining 
for CD3 (green) and IL-17 (red) in cryosections from wild-type (a and b) and 
4/ EAE mice (c and d). Nuclear staining with DAPI is shown (blue). IL-17–
producing T cells (yellow, arrowheads in b and c) were identified in menin-
geal infiltrates of wild-type mice (b) and in the periventricular infiltrates of 
4/ animals (c). The arrow in a indicates a plexus epithelium cell. Bars:  
(A, a and k): 500 µm; (A, b and l) 125 µm; (A, c–j and m–t; B, a–d) 10 µm.2470 Differential CNS homing of Th1 and Th17 cells | Rothhammer et al.
host  mice  that  had  received  4-deficient 
Th17 2D2 cells developed an ataxic EAE 
syndrome (Fig. 8, A and B). 4/ Th1 and 
Th17 2D2 cells were equally suited to re-
locate to the peripheral immune tissue (Fig. 8 C). However, 
4/ Th1 2D2 cells were blocked from entering the CNS 
compartment. In contrast, 4/ Th17 2D2 cells were not 
blocked from trafficking into the CNS and again infiltrated 
preferentially into supraspinal areas of the CNS (Fig. 8 C). 
These data corroborate that 4 expression is required for Th1 
cells, but not for Th17 cells, to access the CNS parenchyma 
and initiate inflammatory lesions, although we cannot formally 
exclude that Th1 cells might also use other integrins in addi-
tion to VLA-4, particularly under conditions of increased tissue 
susceptibility to inflammation like in IFN- receptor–deficient 
mice or under conditions of ongoing inflammation.
Atypical EAE as a result of cerebral infiltration of 4  
integrin–deficient T cells is inhibited by anti-CD11a treatment
Because myelin antigen-specific Th17 cells are able to traffic 
into the CNS parenchyma in the absence of 4 integrin ex-
pression, we wanted to define potential integrin candidates 
that are used by Th17 cells instead of VLA-4. We focused on 
2 integrins because their role in the entry of encephalito-
genic T cells has been confirmed previously (Archelos et al., 
1993). CD4+ T cells infiltrating the brains of both wild-type 
and  4/  mice  expressed  high  amounts  of  integrin  L 
(CD11a) that combines with 2 to form LFA-1 (Fig. 9 A), 
making CD11a a possible candidate for an alternative adhe-
sion molecule in the absence of integrin 4. In contrast to 
4 integrin expression, which was reduced in Th17 cells as 
cytokine-producing CD4+ T cells irrespective of their com-
mitment to IFN- or IL-17 production (Fig. 7, A and B).
To further investigate the actual lineage commitment of   
T cells infiltrating the cerebrum of wild-type versus 4/ ani-
mals, brain-infiltrating CD3+CD4+ T cells from wild-type and 
4/ mice were FACS sorted at the peak of disease and ana-
lyzed as to their gene expression profile by quantitative PCR 
analysis. Notably, CD3+CD4+ effector T cells purified from 
the brain of 4/ mice expressed markedly lower amounts of 
CXCR3 and CCR5 but higher amounts of CCR2, CCR6, 
IL-1R, and IL-23R as compared with their wild-type counter-
parts (Fig. 7 C), suggesting that 4/ T cells infiltrating the 
brain were previously committed to the Th17 lineage in spite 
of their loss in actual production of IL-17A (Hirota et al., 
2011). From these data, we concluded that commitment to the 
Th17 lineage in the peripheral immune compartment licenses 
T cells to enter the CNS, and here particularly the supraspinal 
parts of the CNS, in the absence of 4 integrin expression.
To directly compare the capacity of highly pure MOG35-55-
specific Th17 versus Th1 cells to traffic into the CNS in   
the absence of 4 integrin expression, we crossed 4/ mice 
onto the 2D2 background. Thus, we were able to isolate naive 
(CD4+CD44CD25) MOG35-55 TCR transgenic T cells that 
genetically  lacked 4  expression. 4-deficient  2D2  T  cells 
were differentiated into either Th1 or Th17 cells followed   
by adoptive transfer into Rag1-deficient host mice (Fig. 8). 
Although 4/ Th1 2D2 cells failed to induce any signs of EAE, 
Figure 7.  Flow cytometric analysis of CNS-
infiltrating T cells in MOG35-55-immunized wild-
type versus 4/ mice at the peak of EAE. 
Wild-type and 4/ mice were immunized with 
MOG35-55 plus CFA and, at the peak of disease, cere-
brum and spinal cord were analyzed separately.  
(A) Fraction and cytokine profile of CNS-infiltrating 
CD3+CD4+ T cells. Numbers indicate percentages of 
CD4+ T cells among live mononuclear cells (top row) 
or percentages of cytokine-positive cells within the 
CD3+CD4+ T cell compartment (bottom row, repre-
sentative of five independent experiments). (B) Abso-
lute number of CD4+ T cells within the brain (top row, 
left) or spinal cord (top row, right) of wild-type or 
4/ EAE mice. In the bottom row, absolute num-
bers of IFN-, IL-17, or IFN-/IL-17 double-positive 
CD4+ T cells recovered from the brain or spinal cord 
of wild-type versus 4/ mice are depicted (means + 
SD, n = 5). (C) CD3+CD4+ T cells were highly purified 
by FACS sorting from supraspinal parts of the CNS 
(brain, i.e. brain stem, cerebellum, and cerebrum) of 
MOG35-55-immunized wild-type or 4/ mice at the 
peak of disease. Fold change in relative abundance of 
Cxcr3, Ccr5, Ccr2, Ccr6, Il23r, Il1r1, and IL-22 mRNA 
in 4/ versus wild-type control mice (log scale, 
means + SD, n = 3).JEM Vol. 208, No. 12 
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observation was further corroborated when we analyzed the 
amount of CD4+ T cells infiltrating the brain and spinal cord 
of  the  various  experimental  groups. Whereas  wild-type 
animals displayed elevated CD4+ T cell numbers in the brain 
under CD11a blockade, the infiltration of 4/ T cells was 
efficiently inhibited by anti-CD11a treatment (Fig. 9, E and F). 
Collectively, these data support the idea that under conditions 
of 4 deficiency, infiltration of antigen-specific T cells into 
the brain parenchyma is mediated by L integrin (CD11a), 
which may as well be the preferential adhesion molecule used 
by Th17 cells invading the supraspinal parts of the CNS.
DISCUSSION
In the present study, we investigated the relative importance of 
4  integrin  expression  for  the  migration  of  distinct  effector   
T cell subsets into the CNS during EAE. The key conclusions 
from our genetic and antibody-blocking approaches are that 
encephalitogenic T cells use both 41 and L2 integrins to 
infiltrate into the CNS, that Th1 cells are dependent on 4 in-
tegrin expression to enter into the CNS, and that Th17 cells are 
able to infiltrate into supraspinal parts of the CNS in the absence 
of 4 integrin expression but in an LFA-1–dependent manner.
T cell–associated integrins are required for the firm adhesion 
and diapedesis of encephalitogenic T cells at the luminal mem-
brane of CNS endothelial cells and at the abluminal membrane of 
ependymal cells. Both 41 (VLA-4) and L2 (LFA-1) have 
been implicated in this process (Vajkoczy et al., 2001; Laschinger 
et al., 2002; Engelhardt and Sorokin, 2009). VLA-4 interacts 
with molecules of the extracellular matrix like the fibronectin 
fragment CS-1, but also with VCAM-1 on endothelial cells, and 
mediates firm adhesion of T cells while LFA-1 interacts with 
ICAM-1 or ICAM-2. ICAM-1 participates in attaching T cells 
to the endothelial surface, and both ICAM-1 and ICAM-2 are 
required for T cells to polarize followed by ICAM-1–dependent 
crawling  against  the  blood  stream  under  conditions  of  shear 
(Steiner et al., 2010). These sequential phases (adhesion, crawl-
ing, and diapedesis) have been documented in vitro and   
in vivo using experimental systems that were based on terminally 
committed IFN-–producing encephalitogenic Th1 cells   
(Bartholomäus et al., 2009). However, both Th1 and Th17 cells 
contribute to the induction of inflammation in EAE (Langrish   
et al., 2005; Korn et al., 2007; Jäger et al., 2009; Domingues   
et al., 2010), and it has been proposed that Th1 cells and Th17 
cells differ in their addressin equipment in vitro and in vivo   
(Langrish et al., 2005; Gyülveszi et al., 2009; Kebir et al., 2009).
The amount of 4 integrin expression was significantly 
lower in MOG-specific Th17 cells than in their Th1 counter-
parts. Accordingly, EAE was completely inhibited by blockade 
of 4 in Th1 transfer EAE but not in EAE adoptively transferred 
by Th17 cells. When integrin molecules are only available in 
low concentrations, integrin function is determined by avidity, 
the product of affinity and local clustering of the integrin (lateral 
mobility), which may be more easily blocked by anti-4 anti-
bodies than high-affinity binding of the integrin to its ligand 
alone which is exclusively relevant under conditions of 
high integrin expression. Antibody-mediated blockade of 4   
compared with their Th1 counterparts, in vitro differentiation   
of  both Th1  and Th17  cells  resulted  in  high  amounts  of 
CD11a expression (Fig. 9 B). We hypothesized that T cells 
that lack 4 expression used LFA-1 to enter into the CNS 
parenchyma. To  test  this  hypothesis,  EAE  was  induced  in 
wild-type and conditional 4/ mice, which were subse-
quently treated with i.p. injections of anti-CD11a or isotype 
control antibodies starting on day 5 after immunization to 
avoid an impairment of T cell priming (Fig. 9, C and D). In 
the wild-type group, both isotype and anti-CD11a–treated 
animals developed severe classical EAE (Fig. 9 C). If anything, 
MOG35-55-induced EAE in wild-type mice seemed to be en-
hanced by treatment with anti-CD11a antibodies, supporting 
the idea that sensitization of encephalitogenic T cells in the 
peripheral immune compartment was not reduced upon ad-
ministration of anti-CD11a antibodies according to our treat-
ment regimen. In contrast, in conditional 4/ animals, 
atypical EAE was entirely abolished as long as the animals 
were treated with anti-CD11a (Fig. 9, C and D). This clinical 
Figure 8.  Adoptive transfer of 4-deficient MOG35-55-specific TCR 
transgenic T cells (2D2) into Rag1/ mice after in vitro polarization 
into Th1 or Th17 cells. Naive T cells from 2D2 × CD4 Cre × 4flox/flox mice 
(4/ 2D2) were differentiated into Th1 or Th17 cells in vitro and trans-
ferred into Rag1/ recipient mice. The host mice were followed clinically 
according to the classical EAE score (A) and according to an ataxia score (B). 
Means of clinical scores + SEM for classical and ataxic EAE are depicted 
(two-way ANOVA plus Bonferroni’s post-testing). (C) At the peak of dis-
ease, lymph nodes, spleens, spinal cords, and brains (i.e. brain stem, cer-
ebellum, and cerebrum) were dissected. Mononuclear cells were isolated 
separately and analyzed by flow cytometry. Quantification of absolute 
numbers of 4-deficient 2D2 CD3+CD4+ T cells in lymph nodes and spleen 
(C, top row) and in spinal cord and brain (C, bottom row) reisolated from 
individual host mice (Student’s t test). Horizontal bars indicate mean.2472 Differential CNS homing of Th1 and Th17 cells | Rothhammer et al.
inflammation. However, it has been difficult to dissect the re-
lative contribution of Th1 versus Th17 cells to tissue damage 
because  both  species  are  induced  upon  immunization  with 
MOG35-55/CFA,  and  because  the  role  of  double-producing 
IFN-+/IL-17+ CD4+ T cells, as well as the plasticity of pre-
committed effector Th17 cells that might modify their cytokine 
profile toward production of IFN- during an immune reac-
tion, is incompletely understood in vivo (Lee et al., 2009; Hirota 
et al., 2011). Yet, in vitro differentiated Th1 and Th17 cells have 
exquisitely distinct gene expression profiles. Apart from strict 
differences in the lineage defining genes like Tbx21, Stat1, Stat4, 
and Ifng and Rorc, Rora, Stat3, Il17, Il22, and Il23r for Th1 and 
Th17 cells, respectively (Korn et al., 2009), we found a sustained 
down-regulation of 4 integrin in Th17 cells, whereas Th1 cells 
kept high expression of 4 integrins. We have formally tested 
the hypothesis of differential usage of 4 by Th1 versus Th17 
cells in EAE by analyzing T cell conditional 4/ mice. T cell 
conditional 4/ mice were not protected from actively in-
duced EAE and developed an atypical disease with predominant 
brain stem and forebrain infiltrates of IL-23R–, IL-22–, and 
CCR6-expressing CD4+ T cells, whereas the spinal cord was rel-
atively spared. In contrast, wild-type littermates always showed 
classical EAE with predominant spinal cord infiltrates. Together, 
the clinical and immunopathological phenotypes of actively im-
munized 4/ mice were reminiscent of adoptive transfer EAE 
induced with in vitro differentiated Th17 cells. In contrast, Th1-
induced EAE consistently resulted in spinal cord syndromes.
In a series of studies, effector functions of Th1 and Th17 cells 
have been investigated (Kroenke et al., 2008; O’Connor et al., 
2008; Domingues et al., 2010). In the adoptive transfer model of 
Kroenke et al. (2008), clinical signs of Th1- and Th17-induced 
EAE are indistinguishable, whereas inflammatory infiltrates are 
dominated by macrophages or neutrophils under conditions of 
Th1 or Th17 cell transfer, respectively. However, Th1 and Th17 
responses have also been associated with different topologies of 
infiltration within the CNS during EAE (Stromnes et al., 2008). 
C3H.SW (H-2b) mice develop classical EAE with ascending pa-
ralysis, whereas C3HeB/Fej (H-2k) mice get ataxic disease upon 
immunization with full-length MOG protein. Here, the ratio of 
Th17 versus Th1 cells in the autoantigen-specific immune re-
sponse that develops in the secondary lymphoid organs deter-
mines the site of infiltration in the CNS. When the Th17/Th1 
ratio exceeds 1, brain infiltration with atypical signs of disease 
occurs. When the immune response is dominated by Th1 cells, 
the animals develop classical EAE with spinal cord infiltrates 
(Stromnes et al., 2008). We propose that differential integrin 
equipment might promote the targeting of T helper effector sub-
sets into distinct niches of the CNS. Encephalitogenic T cells of 
the Th17 phenotype are recruited to periventricular areas of the 
CNS in an 4 integrin–independent manner, and it is possible 
that the entry route into the CNS via the cerebrospinal fluid 
space (Brown and Sawchenko, 2007; Kivisäkk et al., 2009b) is 
mainly used by T cells that have been committed to the Th17 
phenotype. When expression of 4 integrin is not mandatory for 
Th17 cells to enter the CNS, which are the molecular cues that 
guide Th17 cells into the CNS? It has been proposed that Th17 
integrins in wild-type C57BL/6 mice fails to abolish MOG35-55- 
induced EAE (Kerfoot et al., 2006; not depicted), suggesting 
that different subsets of encephalitogenic T cells are differen-
tially dependent on 4 integrin expression to induce CNS   
Figure 9.  Atypical EAE in 4/ mice and predominant cerebral T cell 
infiltration are inhibited by administration of blocking antibodies to 
CD11a (L integrin). EAE was induced in wild-type and T cell conditional 
4/ mice by immunization with MOG35-55 plus CFA. (A) Relative expression 
of 4 integrin and CD11a (L integrin) in CD4+ T cells isolated from the brain 
of untreated wild-type or 4/ EAE mice (means + SD, n = 3). (B) Naive wild-
type T cells were cultured under Th1 or Th17 polarizing conditions. On day 4, 
intracellular cytokine staining and surface staining for CD11a (tinted histo-
gram, isotype control; black line, anti-CD11a expression) were performed. 
Shown are representatives of two independent experiments. (C and D) Starting 
from day 5 after induction of EAE in wild-type and 4/ mice, control rat IgG 
or antibodies to CD11a were administered i.p. every other day until the devel-
opment of clinical signs of disease. (C) Means of clinical scores + SEM are de-
picted according to the classical EAE score (n = 6). The rat IgG control-treated 
and anti-CD11a–treated 4/ groups were compared with two-way ANOVA 
and Bonferroni’s post-testing. (D) Treatment effect of anti-CD11a in 4/ 
mice according to the ataxia score (mean + SEM, n = 4). The two groups were 
compared with two-way ANOVA and Bonferroni’s post-testing. (E and F) Abso-
lute numbers of brain-infiltrating T cells isolated at the peak of disease from 
wild-type (E) and 4/ mice (F) without or with anti-CD11a treatment 
(means + SD of absolute CD4+ T cell numbers, n = 6, Student’s t test).JEM Vol. 208, No. 12 
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absence of 4 integrins. When T cells lack expression of 4 in-
tegrins, they can still migrate to supraspinal parts of the CNS 
when they have been committed to the Th17 lineage. In con-
trast, Th1 cells express 4 integrins and 4 integrin expression is 
necessary and sufficient for Th1 cells to enter into the spinal cord 
parenchyma. Thus, analysis of the requirement for specific inte-
grins on the surface of distinct T helper cell subsets might be a 
means to increase our understanding of the topographical distri-
bution of lesions in the CNS during an autoimmune response. 
Indeed, the clinical phenotype and the type of physical handicap 
in EAE and MS are profoundly dependent on whether a given 
inflammatory lesion occurs in the spinal cord or the brain.   
Besides the hypothesis of differential antigen presentation in dif-
ferent parts of the CNS (Bettelli et al., 2006a; Krishnamoorthy   
et al., 2006), in this paper we provide evidence that not only the 
specificity but also the phenotype of T helper effector cells that 
comes along with a specific integrin equipment is an important 
determinant  of  lesion  localization  within  the  CNS.  Because 
anti–VLA-4 (natalizumab) treatment has proven a very efficient 
therapy for human multiple sclerosis and largely abrogates T cell 
trafficking to the CNS (del Pilar Martin et al., 2008; Kivisäkk   
et al., 2009a; Stüve et al., 2009), we propose that human en-
cephalitogenic T cells might more resemble Th1 than Th17 cells 
in the mouse model of EAE. Conversely, MS patients who do 
not respond to natalizumab often have very active and atypical 
disease which might be more akin to a Th17 disease (Berger, 
2008; Rinaldi et al., 2009). Notably, breakthrough disease   
in natalizumab-treated patients with opticospinal MS or neuro-
myelitis optica has been reported to heavily affect supraspinal 
parts of the CNS that are not usually targeted by the im-
mune response in this disease entity in the first place (Barnett   
et al., 2011).
In conclusion, Th1 and Th17 cells depend on 4 and 2 
integrins in a differential manner when migrating into the 
CNS. Thus, a more profound understanding of the func-
tional phenotype of distinct effector T helper cell subsets   
in vivo might help to approach the enigma of random topo-
graphical localization of lesions in MS. Further studies are   
required to define the interplay between the functional 
phenotype of T cells and properties of the host tissue that 
eventually determines the efficacy of immunosurveillance in 
health and the topography of lesion development in disease.
MATERIALS AND METHODS
Animals and induction of EAE. 2D2 MOG35-55 TCR–specific trans-
genic mice (Bettelli et al., 2003), Foxp3gfp.KI mice (Bettelli et al., 2006b; 
Korn et al., 2007), and 4flox/flox mice (Scott et al., 2003) have been described 
previously.  CD4  Cre  mice,  Ifng/  mice,  Rag1/  mice,  and  wild-type 
C57BL/6 mice were obtained from The Jackson Laboratory. All mouse 
strains were on pure C57BL/6 background.
EAE was induced by subcutaneous immunization with 100 µg of an 
emulsion of MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) and 
250 µg Mycobacterium tuberculosis H37Ra (BD) in Freund’s adjuvant oil (CFA) 
plus i.p. injection of 200 ng pertussis toxin (Fluka) on days 0 and 2. For   
in vivo blockade of CD11a, MOG35-55–immunized mice were treated with i.p. 
injections of anti-CD11a (M17/4; Bio-XCell) or isotype control starting on 
day 5 (200 µg) followed by i.p. injections of 100 µg on days 7, 9, and 11 until 
the development of first signs of disease.
cells are capable of using the uninflamed choroid plexus epithe-
lium as a port of entry in a CCR6/CCL20-dependent manner 
(Reboldi et al., 2009), although conflicting results exist on the 
overall susceptibility of CCR6-deficient mice during an inflam-
matory  reaction  and  particularly  during  EAE  (Elhofy  et  al.,   
2009; Villares et al., 2009). Indeed, the amounts of CCR6 and 
IL-23R expression that are associated with the Th17 phenotype   
(Petermann et al., 2010) were higher in CD4+ T cells recovered 
from the cerebrum of 4/ animals than in wild-type controls. 
Chemokine receptors are required to activate integrins for cells 
to adhere to and diapedese through endothelial and epithelial 
barriers. Besides CCR6, Th17 cells express high amounts of 
LFA-1. Notably, antibody blockade of LFA-1 abrogated EAE   
in T cell conditional 4/ mice. Therefore, we provide in vivo 
evidence that encephalitogenic T cells that acquire features of 
the Th17 lineage in the peripheral immune compartment are   
capable of infiltrating the brain stem and forebrain in a VLA-4–
independent but LFA-1–dependent manner. In contrast to 
4/ mice, wild-type mice could not be protected from EAE 
by treatment with anti-CD11a antibodies. This is consistent with 
previous studies on anti–LFA-1 treatment in adoptive transfer 
EAE that was shown to either be inefficient or disease promoting 
(Cannella et al., 1993; Welsh et al., 1993). Based on our observa-
tions in the present study, we propose that blockade of LFA-1 is 
particularly inefficient to prevent Th1 cells from entering the 
CNS. Active induction of EAE in LFA-1 KO mice (Cd11a/) 
has yielded conflicting results (Gültner et al., 2010; Hu et al., 
2010), which might be attributed to the fact that LFA-1 is not 
only involved in diapedesis of T cells across endothelial barriers 
but also has a prominent role as a costimulatory molecule. Yet, 
the interaction of LFA-1 with ICAM-1 has been previously 
identified to support the trafficking of Th17 cells into lung tissue 
and skin in a systemic sclerosis model (Yoshizaki et al., 2010) and 
the transmigration of Th17 cells across a confluent layer of pri-
mary human endothelial cells in vitro (Kebir et al., 2009).
Apart from effector cell intrinsic properties, the tissue re-
sponsiveness to certain cytokines has also been implicated in the 
disease phenotype. When CNS tissue cannot sense IFN-, as 
for example in IFN- receptor–deficient animals, the spinal 
cord appears to be relatively spared from immunopathology, 
whereas infiltrates occur in the brain stem and cerebellum, sug-
gesting that local properties of the target tissue contribute to de-
termining the susceptibility to Th1 versus Th17 responses and 
the extent of immunopathology (Wensky et al., 2005; Lees   
et al., 2008). It is possible that additional tissue-intrinsic proper-
ties, like for example a distinct adhesion molecule expression 
pattern on endothelial and epithelial surfaces in the CNS 
(Steffen et al., 1996), the laminin composition of the basement 
membrane (Wu et al., 2009), the local endothelium associated 
chemokine milieu (Cruz-Orengo et al., 2011), or the structure 
and function of endothelial cell junctions (Schulte et al., 2011), 
contribute not only to the general response of a given organ to 
inflammation but also determine the topography and dynamics 
of inflammatory lesions (Engelhardt and Sorokin, 2009).
On the side of the invading immune cells, our data suggest 
that encephalitogenic T cells are able to enter the CNS in the 2474 Differential CNS homing of Th1 and Th17 cells | Rothhammer et al.
Biosystems. The TaqMan analysis was performed on a StepOne system (Applied 
Biosystems). The gene expression was normalized to the expression of -actin.
Antigen-specific proliferative and cytokine responses. For measure-
ment of proliferation, draining lymph nodes from MOG35-55-immunized 
C57BL/6 wild-type or CD4 Cre × 4flox/flox mice were dissected on day 8   
after immunization. Single cell suspensions were prepared with a 70-µm 
strainer and cells were seeded on a 96-well U-bottom plate at a density of 
200,000 cells. 48 h after restimulation with MOG35-55, cell cultures were 
pulsed with 1.25 µCi 3H/well and incubated for 18 h at 37°C. Incorporation 
of radioactive thymidine was analyzed on a -scintillation counter (1450 
MicroBeta TriLux; PerkinElmer). For CD154 (CD40L) staining, single cell 
suspensions from draining lymph nodes were restimulated with 30 µg/ml 
MOG35-55 for 6 h in the presence of 5 µg/ml brefeldin A during the last 3 h 
of incubation followed by surface and intracellular staining as described.
Histology. Diseased animals were perfused at the peak of disease with cold PBS 
followed by 4% paraformaldehyde fixation, pH 7.4. Brain and spinal cord tissue 
were prepared separately, embedded in Tissue-Tek (Sakura) and cryopreserved 
in liquid nitrogen. Coronal periventricular brain sections and transversal lumbar 
spinal cord sections were cryotomized at 10-µm thickness (CM3050S; Leica). 
For light microscopy, sections were stained with hematoxylin and eosin (Sigma-
Aldrich). For immunofluorescence staining, sections were fixed with 100% ice 
cold methanol followed by blocking steps with peroxidase, avidin, and biotin 
blocking reagents (Vector Laboratories), and with 10% goat serum in PBS-T. 
Sections were then incubated with rat anti–mouse IL-17 (10 µg/ml PBS-T; 
clone  400210;  R&D  Systems)  or  rat  anti–mouse  CD3  (10  µg  per  ml   
PBS-T; clone KT3; AbD Serotec) overnight at 4°C. After multiple washing 
steps, sections were incubated with biotin-tagged anti–rat IgG (1:200 in PBS-T; 
Vector Laboratories), followed by incubation with avidin-biotin complex 
(Vector Laboratories) and biotinylated tyramide. Antibody binding was detected 
with Alexa Fluor 488–labeled avidin (1:1,000) for CD3 or Alexa Fluor 555– 
labeled streptavidin for IL-17 (1:1,000; both Invitrogen). In case of double stain-
ing, the sections were blocked with rat IgG (Vector Laboratories) and goat 
anti–rat IgG Fab fragments (Jackson ImmunoResearch Laboratories) and washed 
extensively with PBS-T before applying the second monoclonal antibody. The 
second monoclonal antibody was detected with directly labeled Alexa Fluor 488 
anti–rat IgG (1:500; Invitrogen). Nuclear staining was performed with Gold   
antifade with DAPI (Invitrogen). Images were taken using a microscope 
(Cell Observer; Carl Zeiss) with a camera (AxioCam MRm; Carl Zeiss).
Statistical Analysis. Statistical evaluations of cell frequency measurements 
and cDNA levels were performed with the unpaired Student’s t test. EAE 
scores and ataxia scores were evaluated with two-way ANOVA and Bonfer-
roni’s post-testing. Two-tailed p-values <0.05 were considered significant.
Online supplemental material. Video 1 shows atypical EAE in Th17-transferred 
and anti-4 antibody-treated Rag1-deficient mice. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20110434/DC1.
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For adoptive transfer experiments, naive FACS-sorted T cells (CD4+ 
CD44Foxp3  or  CD4+CD44CD25)  from  2D2  ×  Foxp3gfp.KI  or 
2D2 × Ifng/ mice were differentiated in vitro in Th1 or Th17 cells. Differ-
entiation status was checked on day 4 by intracellular cytokine staining and 2 ×   
106 cytokine-positive T cells were injected i.v. into Rag1/ recipient mice.   
Before transfer, Th1 and Th17 cells were incubated with blocking antibodies to 
4 integrin (PS/2; Bio-XCell) or 1 µg/ml isotype control (rIgG; R&D Systems). 
Animals were thereafter treated with i.p. PS/2 or 200-µg isotype control antibody 
injections every 3 d until the development of clinical disease. Clinical signs of 
EAE were assessed as reported for classical EAE (Korn et al., 2007). Ataxic EAE 
was scored, as has recently been suggested (Guyenet et al., 2010), by four clinical 
sub-tests and categories of ledge walking, hindlimb clasp, gait ataxia, and kyphosis 
with a maximum of three points in each category resulting in a potential maxi-
mum score of 12 points. Animals were kept in a specific pathogen-free facility at 
the Technical University Munich. All experimental protocols were approved   
by the standing committee for experimentation with laboratory animals of the   
Bavarian state authorities (Az 55.2–1-54-2531-88-08) and performed in accor-
dance with the corresponding guidelines.
T cell differentiation. Cells were cultured in DME with 10% FCS supple-
mented with 5 × 105 M -mercaptoethanol, 1 mM sodium pyruvate, non-
essential amino acids, l-glutamine, 100 U/ml penicillin, and 100 µg/ml 
streptomycin. For in vitro T cell differentiation, CD4+ T cells were purified 
from naive splenocytes and lymph node cells with anti-CD4+ magnetic beads 
(Miltenyi Biotec). For obtaining naive T cells, CD4+ T cells were sorted into 
CD4+CD44Foxp3 T cells by fluorescence activated cell sorting. T cells 
were stimulated for 3–5 d with 4 µg/ml of plate-bound antibody to CD3 
(145-2C11) and 2 µg/ml antibody to CD28 (PV-1). Recombinant cytokines 
were added to the differentiation cultures as indicated: 2 ng/ml human TGF-1, 
50 ng/ml mouse IL-6, 25 ng/ml mouse IL-23, 10 ng/ml mouse IL-12, and 
10 µg/ml anti–IL-4 (R&D Systems). Where indicated, purified naive 2D2 
T cells were differentiated by stimulation with 20 µg/ml MOG35-55 and irradi-
ated (3,000 rd) syngeneic splenocytes in the presence of the described cytokine 
cocktails. For restimulation experiments, T cells were rested after primary 
stimulation in IL-2–containing medium followed by restimulation with 2 µg/ml 
of plate-bound anti-CD3 and 1 µg/ml of soluble anti-CD28 without recom-
binant cytokines or in the presence of 5 ng/ml IL-12 or 5 ng/ml IL-23.
Preparation of CNS mononuclear cells and antibody staining. Mono-
nuclear cells were isolated from the CNS at the peak of disease. After perfusion 
through the left cardiac ventricle with cold PBS, subcranial structures were dis-
sected from cerebrum and spinal cords flushed out with PBS by hydrostatic pres-
sure. For separate analysis of brain and spinal cord, spinal cord was dissected from 
cerebrum and brain stem at the level of the medulla oblongata. CNS tissue was 
digested with 2.5 mg/ml collagenase d (Roche) and 1 mg/ml DNaseI (Sigma-
Aldrich) at 37°C for 45 min. Mononuclear cells were isolated by passing the tissue 
through a 70-µm cell strainer and Percoll gradient (37 over 70%) centrifugation. 
Mononuclear cells were removed from the interphase, washed, and resuspended 
in culture medium for further analysis. Surface staining of T cells was performed 
with antibodies to CD4 (RM4-5), CD3 (14-2C11), CD11a (M17/4 or 2D7), 
CD25 (PC61 or 7D4), CD44 (IM7), CD49d (9C10(MRF4.B)), and CCR6 
(140706). All antibodies were purchased from BD. The biotinylated antibody to 
CD154 (MR1) was purchased from eBioscience.
Intracellular cytokine staining. Cells were stimulated in culture medium 
containing 50 ng/ml PMA (Sigma-Aldrich), 1 µg/ml ionomycin (Sigma- 
Aldrich), and 1 µl/ml monensin (GolgiStop; BD) at 37°C and 5% CO2 for   
4 h. After staining of surface markers, cells were fixed and permeabilized 
(Cytofix/Cytoperm and Perm/Wash buffer; BD), followed by staining with 
monoclonal antibodies to mouse IL-17 or IFN- (BD) and flow cytometric 
analysis (CYAN; Beckmann Coulter).
Quantitative PCR analysis. For quantitative PCR, RNA was extracted from 
magnetic bead–purified or flow cytometry–sorted cells ex vivo or after in vitro 
differentiation using RNeasy columns (QIAGEN). Complementary DNA was 
transcribed as recommended (Applied Biosystems) and used as template for   
quantitative PCR. Primer plus probe mixtures were obtained from Applied   JEM Vol. 208, No. 12 
Article
2475
Gyülvészi,  G.,  S.  Haak,  and  B.  Becher.  2009.  IL-23-driven  encephalo- 
tropism and Th17 polarization during CNS-inflammation in vivo. Eur. 
J. Immunol. 39:1864–1869. http://dx.doi.org/10.1002/eji.200939305
Hirota,  K.,  H.  Yoshitomi,  M.  Hashimoto,  S.  Maeda,  S.  Teradaira,  N. 
Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 
2007. Preferential recruitment of CCR6-expressing Th17 cells to in-
flamed joints via CCL20 in rheumatoid arthritis and its animal model.   
J. Exp. Med. 204:2803–2812. http://dx.doi.org/10.1084/jem.20071397
Hirota, K., J.H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D.J. Cua, H. 
Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping 
of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 
12:255–263. http://dx.doi.org/10.1038/ni.1993
Hu, X., J.E. Wohler, K.J. Dugger, and S.R. Barnum. 2010. beta2-integrins 
in demyelinating disease: not adhering to the paradigm. J. Leukoc. Biol. 
87:397–403. http://dx.doi.org/10.1189/jlb.1009654
Jäger, A., V. Dardalhon, R.A. Sobel, E. Bettelli, and V.K. Kuchroo. 2009. 
Th1, Th17, and Th9 effector cells induce experimental autoimmune 
encephalomyelitis with different pathological phenotypes. J. Immunol. 
183:7169–7177. http://dx.doi.org/10.4049/jimmunol.0901906
Kebir, H., I. Ifergan, J.I. Alvarez, M. Bernard, J. Poirier, N. Arbour, P. 
Duquette, and A. Prat. 2009. Preferential recruitment of interferon-
gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66: 
390–402. http://dx.doi.org/10.1002/ana.21748
Kerfoot, S.M., M.U. Norman, B.M. Lapointe, C.S. Bonder, L. Zbytnuik, 
and P. Kubes. 2006. Reevaluation of P-selectin and alpha 4 integrin as 
targets for the treatment of experimental autoimmune encephalomyeli-
tis. J. Immunol. 176:6225–6234.
Kivisäkk, P., B.C. Healy, V. Viglietta, F.J. Quintana, M.A. Hootstein, H.L. 
Weiner, and S.J. Khoury. 2009a. Natalizumab treatment is associated 
with  peripheral  sequestration  of  proinflammatory  T  cells.  Neurology. 
72:1922–1930. http://dx.doi.org/10.1212/WNL.0b013e3181a8266f
Kivisäkk,  P.,  J.  Imitola,  S.  Rasmussen,  W.  Elyaman,  B.  Zhu,  R.M. 
Ransohoff, and S.J. Khoury. 2009b. Localizing central nervous system 
immune surveillance: meningeal antigen-presenting cells activate T cells 
during  experimental  autoimmune  encephalomyelitis.  Ann.  Neurol. 
65:457–469. http://dx.doi.org/10.1002/ana.21379
Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T.R. Petersen, B.T. 
Bäckström, R.A. Sobel, K.W. Wucherpfennig, T.B. Strom, et al. 2007. 
Myelin-specific regulatory T cells accumulate in the CNS but fail to 
control autoimmune inflammation. Nat. Med. 13:423–431. http://dx 
.doi.org/10.1038/nm1564
Korn, T., E. Bettelli, M. Oukka, and V.K. Kuchroo. 2009. IL-17 and Th17 
Cells.  Annu.  Rev.  Immunol.  27:485–517.  http://dx.doi.org/10.1146/ 
annurev.immunol.021908.132710
Krishnamoorthy,  G.,  H.  Lassmann,  H.  Wekerle,  and  A.  Holz.  2006. 
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse 
model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116:2385– 
2392. http://dx.doi.org/10.1172/JCI28330
Kroenke, M.A., T.J. Carlson, A.V. Andjelkovic, and B.M. Segal. 2008. 
IL-12– and IL-23–modulated T cells induce distinct types of EAE 
based on histology, CNS chemokine profile, and response to cytokine 
inhibition. J. Exp. Med. 205:1535–1541. http://dx.doi.org/10.1084/ 
jem.20080159
Kuchroo, V.K., C.A. Martin, J.M. Greer, S.T. Ju, R.A. Sobel, and M.E. 
Dorf. 1993. Cytokines and adhesion molecules contribute to the ability 
of myelin proteolipid protein-specific T cell clones to mediate experi-
mental allergic encephalomyelitis. J. Immunol. 151:4371–4382.
Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. 
Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and 
B7-2 costimulatory molecules activate differentially the Th1/Th2 de-
velopmental pathways: application to autoimmune disease therapy. Cell. 
80:707–718. http://dx.doi.org/10.1016/0092-8674(95)90349-6
Kurschus, F.C., A.L. Croxford, A.P. Heinen, S. Wörtge, D. Ielo, and A. Waisman. 
2010. Genetic proof for the transient nature of the Th17 phenotype. Eur.   
J. Immunol. 40:3336–3346. http://dx.doi.org/10.1002/eji.201040755
Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. 
Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 
drives a pathogenic T cell population that induces autoimmune inflamma-
tion. J. Exp. Med. 201:233–240. http://dx.doi.org/10.1084/jem.20041257
reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 
182:5904–5908. http://dx.doi.org/10.4049/jimmunol.0900732
Barnett, M., J. Prineas, M. Buckland, J. Parratt, and J. Pollard. 2011. Massive 
astrocyte destruction in neuromyelitis optica despite natalizumab ther-
apy. Mult. Scler.
Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway Jr. 
1993. Surface expression of 4 integrin by CD4 T cells is required for 
their entry into brain parenchyma. J. Exp. Med. 177:57–68. http://dx 
.doi.org/10.1084/jem.177.1.57
Bartholomäus, I., N. Kawakami, F. Odoardi, C. Schläger, D. Miljkovic, J.W. 
Ellwart, W.E. Klinkert, C. Flügel-Koch, T.B. Issekutz, H. Wekerle, 
and A. Flügel. 2009. Effector T cell interactions with meningeal vascu-
lar structures in nascent autoimmune CNS lesions. Nature. 462:94–98. 
http://dx.doi.org/10.1038/nature08478
Berger, J.R. 2008. Paradoxically aggressive multiple sclerosis in the face 
of  natalizumab  therapy.  Mult.  Scler.  14:708–710.  http://dx.doi.org/ 
10.1177/1352458507087135
Bettelli, E., M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. 
Kuchroo. 2003. Myelin oligodendrocyte glycoprotein–specific T cell re-
ceptor transgenic mice develop spontaneous autoimmune optic neuritis.   
J. Exp. Med. 197:1073–1081. http://dx.doi.org/10.1084/jem.20021603
Bettelli, E., D. Baeten, A. Jäger, R.A. Sobel, and V.K. Kuchroo. 2006a. 
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate 
to induce a Devic-like disease in mice. J. Clin. Invest. 116:2393–2402. 
http://dx.doi.org/10.1172/JCI28334
Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. 
Weiner, and V.K. Kuchroo. 2006b. Reciprocal developmental path-
ways for the generation of pathogenic effector TH17 and regulatory   
T cells. Nature. 441:235–238. http://dx.doi.org/10.1038/nature04753
Brown, D.A., and P.E. Sawchenko. 2007. Time course and distribution 
of inflammatory and neurodegenerative events suggest structural bases 
for the pathogenesis of experimental autoimmune encephalomyelitis.   
J. Comp. Neurol. 502:236–260. http://dx.doi.org/10.1002/cne.21307
Cannella, B., A.H. Cross, and C.S. Raine. 1993. Anti-adhesion molecule ther-
apy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 
46:43–55. http://dx.doi.org/10.1016/0165-5728(93)90232-N
Cruz-Orengo,  L.,  D.W.  Holman,  D.  Dorsey,  L.  Zhou,  P.  Zhang,  M. 
Wright, E.E. McCandless, J.R. Patel, G.D. Luker, D.R. Littman, et al. 
2011. CXCR7 influences leukocyte entry into the CNS parenchyma 
by controlling abluminal CXCL12 abundance during autoimmunity.   
J. Exp. Med. 208:327–339. http://dx.doi.org/10.1084/jem.20102010
del Pilar Martin, M., P.D. Cravens, R. Winger, E.M. Frohman, M.K. Racke, 
T.N. Eagar, S.S. Zamvil, M.S. Weber, B. Hemmer, N.J. Karandikar,   
et al. 2008. Decrease in the numbers of dendritic cells and CD4+ T cells   
in  cerebral  perivascular  spaces  due  to  natalizumab.  Arch.  Neurol. 
65:1596–1603. http://dx.doi.org/10.1001/archneur.65.12.noc80051
Domingues,  H.S.,  M.  Mues,  H.  Lassmann,  H.  Wekerle,  and  G. 
Krishnamoorthy. 2010. Functional and pathogenic differences of Th1 
and Th17 cells in experimental autoimmune encephalomyelitis. PLoS 
ONE. 5:e15531. http://dx.doi.org/10.1371/journal.pone.0015531
Durelli, L., L. Conti, M. Clerico, D. Boselli, G. Contessa, P. Ripellino, 
B. Ferrero, P. Eid, and F. Novelli. 2009. T-helper 17 cells expand in 
multiple  sclerosis  and  are  inhibited  by  interferon-beta.  Ann.  Neurol. 
65:499–509. http://dx.doi.org/10.1002/ana.21652
Elhofy, A., R.W. Depaolo, S.A. Lira, N.W. Lukacs, and W.J. Karpus. 2009. 
Mice deficient for CCR6 fail to control chronic experimental auto-
immune encephalomyelitis. J. Neuroimmunol. 213:91–99. http://dx.doi 
.org/10.1016/j.jneuroim.2009.05.011
Engelhardt, B., and L. Sorokin. 2009. The blood-brain and the blood- 
cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 
31:497–511. http://dx.doi.org/10.1007/s00281-009-0177-0
Gültner, S., T. Kuhlmann, A. Hesse, J.P. Weber, C. Riemer, M. Baier, and 
A. Hutloff. 2010. Reduced Treg frequency in LFA-1-deficient mice   
allows enhanced T effector differentiation and pathology in EAE. Eur.   
J. Immunol. 40:3403–3412. http://dx.doi.org/10.1002/eji.201040576
Guyenet, S.J., S.A. Furrer, V.M. Damian, T.D. Baughan, A.R. La Spada, 
and  G.A.  Garden.  2010.  A  simple  composite  phenotype  scoring   
system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp. 
pii:1787.2476 Differential CNS homing of Th1 and Th17 cells | Rothhammer et al.
Laschinger, M., P. Vajkoczy, and B. Engelhardt. 2002. Encephalitogenic   
T cells use LFA-1 for transendothelial migration but not during capture 
and initial adhesion strengthening in healthy spinal cord microvessels   
in vivo. Eur. J. Immunol. 32:3598–3606. http://dx.doi.org/10.1002/1521-
4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6
Lee, Y.K., H. Turner, C.L. Maynard, J.R. Oliver, D. Chen, C.O. Elson, and 
C.T. Weaver. 2009. Late developmental plasticity in the T helper 17 lineage. 
Immunity. 30:92–107. http://dx.doi.org/10.1016/j.immuni.2008.11.005
Lees, J.R., P.T. Golumbek, J. Sim, D. Dorsey, and J.H. Russell. 2008. 
Regional CNS responses to IFN- determine lesion localization pat-
terns during EAE pathogenesis. J. Exp. Med. 205:2633–2642. http://
dx.doi.org/10.1084/jem.20080155
Lowes, M.A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L.C. Zaba, A.S. 
Haider, E.P. Bowman, and J.G. Krueger. 2008. Psoriasis vulgaris lesions 
contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 
128:1207–1211. http://dx.doi.org/10.1038/sj.jid.5701213
Manel, N., D. Unutmaz, and D.R. Littman. 2008. The differentiation of 
human T(H)-17 cells requires transforming growth factor-beta and in-
duction of the nuclear receptor RORgammat. Nat. Immunol. 9:641–
649. http://dx.doi.org/10.1038/ni.1610
Mangan, P.R., L.E. Harrington, D.B. O’Quinn, W.S. Helms, D.C. Bullard, 
C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver. 
2006. Transforming growth factor-beta induces development of the T(H)17 
lineage. Nature. 441:231–234. http://dx.doi.org/10.1038/nature04754
McGeachy,  M.J.,  Y.  Chen,  C.M.  Tato,  A.  Laurence,  B.  Joyce-Shaikh, 
W.M. Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 
2009. The interleukin 23 receptor is essential for the terminal differen-
tiation of interleukin 17-producing effector T helper cells in vivo. Nat. 
Immunol. 10:314–324. http://dx.doi.org/10.1038/ni.1698
Mittelbrunn, M., A. Molina, M.M. Escribese, M. Yáñez-Mó, E. Escudero, 
A.  Ursa,  R.  Tejedor,  F.  Mampaso,  and  F.  Sánchez-Madrid.  2004. 
VLA-4 integrin concentrates at the peripheral supramolecular activation 
complex of the immune synapse and drives T helper 1 responses. Proc. 
Natl. Acad. Sci. USA. 101:11058–11063. http://dx.doi.org/10.1073/ 
pnas.0307927101
Murphy, C.A., C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, 
R.A. Kastelein, J.D. Sedgwick, and D.J. Cua. 2003. Divergent pro- and 
antiinflammatory roles for IL-23 and IL-12 in joint autoimmune in-
flammation. J. Exp. Med. 198:1951–1957. http://dx.doi.org/10.1084/ 
jem.20030896
O’Connor, R.A., C.T. Prendergast, C.A. Sabatos, C.W. Lau, M.D. Leech, 
D.C. Wraith, and S.M. Anderton. 2008. Cutting edge: Th1 cells facili-
tate the entry of Th17 cells to the central nervous system during experi-
mental autoimmune encephalomyelitis. J. Immunol. 181:3750–3754.
Petermann, F., V. Rothhammer, M.C. Claussen, J.D. Haas, L.R. Blanco, S. 
Heink, I. Prinz, B. Hemmer, V.K. Kuchroo, M. Oukka, and T. Korn. 
2010.  T cells enhance autoimmunity by restraining regulatory T cell   
responses via an interleukin-23-dependent mechanism. Immunity. 33:351– 
363. http://dx.doi.org/10.1016/j.immuni.2010.08.013
Polman, C.H., P.W. O’Connor, E. Havrdova, M. Hutchinson, L. Kappos, 
D.H. Miller, J.T. Phillips, F.D. Lublin, G. Giovannoni, A. Wajgt, et al; 
AFFIRM Investigators. 2006. A randomized, placebo-controlled trial   
of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354:899–
910. http://dx.doi.org/10.1056/NEJMoa044397
Pribila, J.T., A.C. Quale, K.L. Mueller, and Y. Shimizu. 2004. Integrins and   
T cell-mediated immunity. Annu. Rev. Immunol. 22:157–180. http://dx.doi 
.org/10.1146/annurev.immunol.22.012703.104649
Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. 
Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. 
C-C chemokine receptor 6-regulated entry of TH-17 cells into the 
CNS through the choroid plexus is required for the initiation of EAE. 
Nat. Immunol. 10:514–523. http://dx.doi.org/10.1038/ni.1716
Rinaldi, F., P. Perini, M. Calabrese, L. Rinaldi, and P. Gallo. 2009. Severe 
relapses after the first infusion of natalizumab in active relapsing- 
remitting multiple sclerosis. Mult. Scler. 15:1359–1362. http://dx.doi 
.org/10.1177/1352458509107011
Schulte, D., V. Küppers, N. Dartsch, A. Broermann, H. Li, A. Zarbock, O. 
Kamenyeva, F. Kiefer, A. Khandoga, S. Massberg, and D. Vestweber. 
2011. Stabilizing the VE-cadherin-catenin complex blocks leukocyte 
extravasation and vascular permeability. EMBO J.
Scott, L.M., G.V. Priestley, and T. Papayannopoulou. 2003. Deletion of 
alpha4 integrins from adult hematopoietic cells reveals roles in homeo-
stasis, regeneration, and homing. Mol. Cell. Biol. 23:9349–9360. http://
dx.doi.org/10.1128/MCB.23.24.9349-9360.2003
Steffen, B.J., G. Breier, E.C. Butcher, M. Schulz, and B. Engelhardt. 1996. 
ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus 
epithelium but not endothelium and mediate binding of lymphocytes   
in vitro. Am. J. Pathol. 148:1819–1838.
Steiner,  O.,  C.  Coisne,  R.  Cecchelli,  R.  Boscacci,  U.  Deutsch,  B.  
Engelhardt, and R. Lyck. 2010. Differential roles for endothelial ICAM-1, 
ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, 
and directed crawling on blood-brain barrier endothelium. J. Immunol. 
185:4846–4855. http://dx.doi.org/10.4049/jimmunol.0903732
Stromnes, I.M., L.M. Cerretti, D. Liggitt, R.A. Harris, and J.M. Goverman. 
2008. Differential regulation of central nervous system autoimmunity 
by T(H)1 and T(H)17 cells. Nat. Med. 14:337–342. http://dx.doi.org/ 
10.1038/nm1715
Stüve, O., P.D. Cravens, E.M. Frohman, J.T. Phillips, G.M. Remington, 
G. von Geldern, S. Cepok, M.P. Singh, J.W. Tervaert, M. De Baets, 
et al. 2009. Immunologic, clinical, and radiologic status 14 months after 
cessation of natalizumab therapy. Neurology. 72:396–401. http://dx.doi 
.org/10.1212/01.wnl.0000327341.89587.76
Vajkoczy, P., M. Laschinger, and B. Engelhardt. 2001. Alpha4-integrin-
VCAM-1 binding mediates G protein-independent capture of encepha-
litogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 
108:557–565.
Villares, R., V. Cadenas, M. Lozano, L. Almonacid, A. Zaballos, C. 
Martínez-A, and R. Varona. 2009. CCR6 regulates EAE pathogen-
esis by controlling regulatory CD4+ T-cell recruitment to target tis-
sues. Eur. J. Immunol. 39:1671–1681. http://dx.doi.org/10.1002/eji 
.200839123
von Andrian, U.H., and B. Engelhardt. 2003. Alpha4 integrins as therapeu-
tic targets in autoimmune disease. N. Engl. J. Med. 348:68–72. http://
dx.doi.org/10.1056/NEJMe020157
Wang, Y., H. Kai, F. Chang, K. Shibata, S. Tahara-Hanaoka, S. Honda, A. 
Shibuya, and K. Shibuya. 2007. A critical role of LFA-1 in the develop-
ment of Th17 cells and induction of experimental autoimmune enceph-
alomyelytis. Biochem. Biophys. Res. Commun. 353:857–862. http://dx 
.doi.org/10.1016/j.bbrc.2006.12.104
Welsh, C.T., J.W. Rose, K.E. Hill, and J.J. Townsend. 1993. Augmentation 
of  adoptively  transferred  experimental  allergic  encephalomyelitis  by 
administration  of  a  monoclonal  antibody  specific  for  LFA-1  alpha.   
J. Neuroimmunol. 43:161–167. http://dx.doi.org/10.1016/0165-5728(93) 
90087-F
Wensky, A.K., G.C. Furtado, M.C. Marcondes, S. Chen, D. Manfra, S.A. 
Lira, D. Zagzag, and J.J. Lafaille. 2005. IFN-gamma determines dis-
tinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 
174:1416–1423.
Wu, C., F. Ivars, P. Anderson, R. Hallmann, D. Vestweber, P. Nilsson, H. 
Robenek, K. Tryggvason, J. Song, E. Korpos, et al. 2009. Endothelial 
basement membrane laminin alpha5 selectively inhibits T lymphocyte 
extravasation into the brain. Nat. Med. 15:519–527. http://dx.doi.org/ 
10.1038/nm.1957
Yednock, T.A., C. Cannon, L.C. Fritz, F. Sanchez-Madrid, L. Steinman, 
and N. Karin. 1992. Prevention of experimental autoimmune encepha-
lomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 356:63–
66. http://dx.doi.org/10.1038/356063a0
Yoshizaki, A., K. Yanaba, Y. Iwata, K. Komura, A. Ogawa, Y. Akiyama, 
E. Muroi, T. Hara, F. Ogawa, M. Takenaka, et al. 2010. Cell adhesion 
molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in 
a bleomycin-induced scleroderma model. J. Immunol. 185:2502–2515. 
http://dx.doi.org/10.4049/jimmunol.0901778
Zheng, Y., D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, 
J.  Wu,  and  W.  Ouyang.  2007.  Interleukin-22,  a  T(H)17  cytokine, 
mediates IL-23-induced dermal inflammation and acanthosis. Nature. 
445:648–651. http://dx.doi.org/10.1038/nature05505